The objective of this study is to explore and validate a novel prognostic index for patients with locally advanced or metastatic biliary tract cancer (BTC) treated with first‐line therapy with cisplatin, gemcitabine, and durvalumab.
M. Persano, A. Casadei-Gardini, L. Fornaro et al.· Cancer· 0 citations
In LARC, CRT reshapes the type and amount of immune cell contents, and the effects on certain immune populations are associated with tumor regression and clinical outcome.
Francesca Negri, L. Bottarelli, L. Gnetti et al.· JCO Precision Oncology· 0 citations
Simple Summary Squamous cell carcinoma of the anal canal (SCAC) is a rare malignancy whose incidence has been increasing worldwide. The main etiological factor is HPV infection, particularly in association with HIV infection and other immunosuppressive conditions. The majority of patients present with localized disease...
Matilde Callegarin, Valentina Angerilli, J. Gasparello et al.· Cancers· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
